Drs. Peter McCullough and Howard Fink share their thoughts on whether or not physicians should screen the population for CKD.
A new study looking at national treatment trends in the surgical management of patients with kidney disease is raising some concerns.
Ghrelin is metabolized by the kidney; thus serum levels are elevated in chronic kidney disease populations.
Patients experience relief with the use of gabapentin and pregabalin.
Systemic review suggests allopurinol can significantly improve estimated glomerular filtration rates.
SWL is an independent risk factor for hypertension in patients without CKD.
Male gender and older age found to be significantly associated with chronic kidney disease before and surgery.
Chronic kidney disease 2.5 times less likely to develop in those who drink more than 4.3 liters a day versus less than two liters day.
Cysteamine bitartrate demonstrated a consistent rate of cystine depletion in a 12-hour dosing period.
Study reveals a significantly higher annual and five-year incidence of albumurinia in vitamin D deficient individuals.
Risk is threefold greater when compared with partial nephrectomy.
A 15-year follow-up study showed that bad eating habits increased microalbuminuria risk twofold.
CKD stage 3a or higher will develop in more than 50% of Americans during their lifetime, according to a new estimate.
The mortality risk was 20% lower for subjects who were regularly physically active compared with those who engaged in no physical activity.
In a study, patients seen by a nephrologist were younger, more likely to be women, and had more comorbidities.
Risk of recurrent bleeding is similar to that of patients with normal kidney function.
Researchers observe an increased incidence of pre-term delivery and infants who are small for gestational age.
Researchers have confirmed findings showing that racial differences in markers of mineral metabolism in patients with CKD.